Nucala (mepolizumab) - GSK
Dupixent (dupilumab) - Sanofi, Regeneron
Development Of Psoriasis After Treatment Of Asthma With Dupilumab And Mepolizumab: Lessons In Immune Polarization (ACAAI 2026) - Oct 28, 2026 - Abstract #M001; Pres time: Nov 13, 2026; 02:35 PM - 06:00 PM; Location: Phoenix Convention Center • North Halls 4–6 (Lower Level); Monitor 1; No abstract available 
Asthma • Dermatology • Immunology • Psoriasis • Respiratory Diseases
https://annualmeeting.acaai.org/2026/submit_abstract.cfm
 
Oct 28, 2026
 
Prev Next